Activated polymer container means and assay method employing the same

Claim 2

Means for the determination of ligand content in aqueous samples, comprising: a plurality of molded polyamide polymer test tubes made by molding polymeric polyamide plastic feed stock at controlled mold temperature for stability such that each has a ligand-free inner wall surface of given area formed with thermally activated ligand-specific binding sides whereby the ligand binding capacity for assay purposes is uniform from tube to tube, a first reagent comprising labeled ligand, a second reagent comprising ligand binding protein, the first reagent being intended to be contacted in respective ones of the test tubes with a sample containing the ligand and with the second reagent to bind part of the labeled and unlabeled ligand to the wall surface of each such test tube to produce a two-phase system, the two-phase system comprising a solid phase and a liquid phase wherein the solid phase includes the bound part of the labeled and unlabeled ligand and the liquid phase includes the unbound labeled and unlabeled ligand, and the label value of each phase when separated being a function of the ligand concentration that is referable to standards and controls.

Claim 3

Means according to claim 1 where the ligand is an iodothyronine compound.

Claim 4

Means according to claim 2 where the ligand is thyroxine.

Claim 5

Means according to claim 2 where the ligand is triiodothyronine.

Claim 6

A molded polymer container or test tube for an aqueous biological or clinical sample for assay purposes, made by molding polymeric polyamide plastic feed stock at controlled mold temperature such that the wall surface of the resulting molded tube is formed with thermally activated binding sites serving, during assay, for binding attachment to any measurable quantity of attachable ligand or ligand conjugate present in the aqueous content of the thus activated, molded container tube.

Claim 7

A molded polymer container or test tube for an aqueous biological or clinical sample for assay purposes, made by molding polymeric polyamide plastic feed stock at controlled mold temperature such that the wall surface of the resulting molded tube is formed with thermally activated binding sites serving, during assay, for binding attachment to any measurable quantity of attachable ligand or ligand conjugate present in the aqueous content of the thus activated, molded container tube.

Claim 8

A container tube according to claim 5 where the polyamide plastic is nylon 6.

Claim 9

A container tube according to claim 5 where the mold temperature is in the range from about 450° to about 530° F.

Claim 10

A container tube according to claim 5 where the mold temperature is about 480° F.

Claim 11

A container tube according to claim 5 having binding sites for attachment to an iodothyronine ligand.

Claim 12

A container tube according to claim 5 having binding sites for attachment to thyroxine.

Claim 13

A container tube according to claim 5 having binding sites for attachment to triiodothyronine.

Claim 14

An assay method for the determination of ligand content in aqueous samples which comprises: providing a plurality of molded polyamide polymer test tubes made by molding polymeric plastic feed stock at controlled mold temperatures for stability such that the resulting tubes each have a ligand-free inner wall surface of given area formed with thermally activated ligand-specific binding sites whereby the ligand binding capacity for assay purposes is uniform from tube to tube, providing a tube set comprising said tubes each containing an aqueous sample of unlabeled ligand in admixture with labeled ligand binding protein, and further ones of said tubes containing comparable standards and controls incubating the mixtures contained in the tubes to achieve an end point wherein labeled and unlabeled ligand is bound to the respective tubes as a solid phase while unbound labeled and unlabeled ligand remains in the respective tubes as a liquid phase, separating the respective solid and liquid phases for each sample, and measuring the ligand content with respect to each sample as a function of the label value of at least one of the phases for that sample in relation to the standards and controls.

Claim 15

An assay method for the determination of ligand content in aqueous samples which comprises: providing a plurality of molded polyamide polymer test tubes made by molding polymeric plastic feed stock at controlled mold temperatures for stability such that the resulting tubes each have a ligand-free inner wall surface of given area formed with thermally activated ligand-specific binding sites whereby the ligand binding capacity for assay purposes is uniform from tube to tube, providing a tube set comprising said tubes each containing an aqueous sample of unlabeled ligand in admixture with labeled ligand binding protein, and further ones of said tubes containing comparable standards and controls incubating the mixtures contained in the tubes to achieve an end point wherein labeled and unlabeled ligand is bound to the respective tubes as a solid phase while unbound labeled and unlabeled ligand remains in the respective tubes as a liquid phase, separating the respective solid and liquid phases for each sample, and measuring the ligand content with respect to each sample as a function of the label value of at least one of the phases for that sample in relation to the standards and controls.

Claim 16

The method of claim 12 where the ligand is labeled with a radioactive isotope of iodine.

Claim 17

The method of claim 13 where the radioactive isotope is 125 I.

Claim 18

The method of claim 12 where the polyamide polymer comprises nylon 6.

Claim 19

The method of claim 15 where the test tubes are produced by injection molding at a mold temperature in the range from about 450° to about 530° F.

Claim 20

The method of claim 15 where the test tubes are produced by injection molding at a mold temperature of about 480° F.

Claim 21

The method of claim 12 where the ligand is an iodothyronine compound.

Claim 22

The method of claim 12 where the ligand is thyroxine.

Claim 23

The method of claim 12 where the ligand is triiodothyronine.